In this episode of Polyp Gossip, we uncover the truth about steroids in CRSwNP—exploring their benefits, limitations, and impact on long-term management. Our experts cut through the myths to reveal what every patient and clinician should really know.
All content for Polyp Gossip is the property of Sanofi and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
In this episode of Polyp Gossip, we uncover the truth about steroids in CRSwNP—exploring their benefits, limitations, and impact on long-term management. Our experts cut through the myths to reveal what every patient and clinician should really know.
Episode 7: Unified Airways: Bridging Type 2 and Comorbidities in CRSwNP
Polyp Gossip
20 minutes
5 months ago
Episode 7: Unified Airways: Bridging Type 2 and Comorbidities in CRSwNP
What links CRSwNP, asthma, and other comorbidities? In this episode, our experts unpack the unified airways concept and why it’s key to understanding Type 2 inflammation and optimizing patient care. Our experts discuss integrated care approaches and what they mean for clinical practice.
Polyp Gossip
In this episode of Polyp Gossip, we uncover the truth about steroids in CRSwNP—exploring their benefits, limitations, and impact on long-term management. Our experts cut through the myths to reveal what every patient and clinician should really know.
